Product Program year 2025 Source: CMS Open Payments

Endopath Xcel

Device Endo-Mechanical

PDI 10705036002291

Open in the dashboard

General payments

$162,721

311 payments

Research payments

$0

0 payments

Through program year 2025, $162,721 in general payments and $0 in research payments were reported against Endopath Xcel (Endo-Mechanical).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $6,612 80
2024 General $3,595 64
2023 General $16,835 79
2022 General $132,102 84
2021 General $3,578 4

Breakdown

Who paid General payments · program years 2021–2025
  1. Medical Device Business Services, Inc. $129,385 63 payments
  2. Ethicon Inc. $24,880 6 payments
  3. Ethicon US, LLC $7,938 223 payments
  4. Johnson and Johnson International $518 19 payments
Top recipients General payments · program year 2025
  1. Ildiko Lingvay Endocrinology, Diabetes & Metabolism · Dallas, TX $3,000 45% · 1 payment
  2. David Cummings Seattle, WA $740 11% · 1 payment
  3. John Diaz Gynecologic Oncology · Miami, FL $134 2% · 2 payments
  4. Esber Nabeeh Shea Samara Urology · Oklahoma City, OK $134 2% · 1 payment
  5. Josiah Wagler Surgery · Oklahoma City, OK $134 2% · 1 payment

The top 5 of 77 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $3,000 51% · 1 practitioner
  2. Surgery $1,048 18% · 22 practitioners
  3. Physician Assistant $406 7% · 8 practitioners
  4. Obstetrics & Gynecology $346 6% · 14 practitioners
  5. Gynecologic Oncology Obstetrics & Gynecology $208 4% · 2 practitioners

The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $3,221 49% · 10 recipients
  2. Florida $1,204 18% · 20 recipients
  3. Washington $740 11% · 1 recipient
  4. Oklahoma $267 4% · 2 recipients
  5. Michigan $211 3% · 7 recipients

The top 5 of 19 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

311 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record